FIAC vs. TCRX

Last updated Jun 4, 2026

FIAC (Focus Impact Acquisition Corp.) and TCRX (TScan Therapeutics, Inc.) are both stocks. FIAC operates in Shell Companies (Financial Services), while TCRX operates in Biotechnology (Healthcare). At a correlation of -0.00, they often move in opposite directions.

Performance

FIAC vs. TCRX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Focus Impact Acquisition Corp. (FIAC) and TScan Therapeutics, Inc. (TCRX). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

FIAC

• 1D: —
• 1M: —
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

TCRX

• 1D: -0.82%
• 1M: -20.33%
• YTD: -2.80%
• 6M: -4.71%
• 1Y: -44.46%
• 3Y*: -29.80%
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

FIAC vs. TCRX - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021
FIAC Focus Impact Acquisition Corp.	0.00%	0.00%	-81.54%	6.97%	3.14%	-0.30%
TCRX TScan Therapeutics, Inc.	-2.80%	-67.11%	-47.86%	276.13%	-65.56%	-7.41%

Correlation

The correlation between FIAC and TCRX is -0.00, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (3Y) Calculated over the trailing 3-year period	-0.00
Correlation (All Time) Calculated using the full available price history since Dec 27, 2021	-0.00

Fundamentals

Market Cap FIAC : $8.56M TCRX : $126.28M
EPS FIAC : -$1.66 TCRX : -$0.96
PS Ratio FIAC : 328.00 TCRX : 15.48
Total Revenue (TTM) FIAC : $18.31K TCRX : $8.15M
Gross Profit (TTM) FIAC : $6.96K TCRX : $6.66M
EBITDA (TTM) FIAC : -$5.47M TCRX : -$129.32M

Return for Risk

FIAC vs. TCRX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

TCRX

TCRX Risk / Return Rank: 20
TCRX Sharpe Ratio Rank: 18
TCRX Sortino Ratio Rank: 23
TCRX Omega Ratio Rank: 23
TCRX Calmar Ratio Rank: 16
TCRX Martin Ratio Rank: 21

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

FIAC vs. TCRX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Focus Impact Acquisition Corp. (FIAC) and TScan Therapeutics, Inc. (TCRX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

Sharpe Ratios by Period

	FIAC	TCRX	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	—	-0.52	—
Sharpe Ratio (All Time) Calculated using the full available price history	—	-0.39	—

Drawdowns

Drawdown Indicators

	FIAC	TCRX	Difference
Max Drawdown Largest peak-to-trough decline	—	-93.36%	—
Max Drawdown (1Y) Largest decline over 1 year	—	-64.46%	—
Max Drawdown (3Y) Largest decline over 3 years	—	-90.58%	—
Current Drawdown Current decline from peak	—	-92.79%	—
Average Drawdown Average peak-to-trough decline	—	-71.82%	—
Ulcer Index Depth and duration of drawdowns from previous peaks	—	44.25%	—

Volatility

Volatility by Period

	FIAC	TCRX	Difference
Volatility (1M) Calculated over the trailing 1-month period	—	17.58%	—
Volatility (6M) Calculated over the trailing 6-month period	—	50.67%	—
Volatility (1Y) Calculated over the trailing 1-year period	—	87.56%	—
Volatility (5Y) Calculated over the trailing 5-year period, annualized	—	98.20%	—
Volatility (10Y) Calculated over the trailing 10-year period, annualized	—	98.20%	—

Dividends

FIAC vs. TCRX - Dividend Comparison

Neither FIAC nor TCRX has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

Frequently Asked Questions

Can I hold both FIAC and TCRX in my portfolio?

FIAC and TCRX have a correlation of -0.00, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.